株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ヒト成長ホルモン(HGH)の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2020年~2025年)

Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

発行 IMARC Services Private Limited 商品コード 945224
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
ヒト成長ホルモン(HGH)の世界市場:業界動向、市場シェア・規模・成長率・機会および予測(2020年~2025年) Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日: 2020年06月18日 ページ情報: 英文 110 Pages
概要

世界のヒト成長ホルモン(HGH)市場は現在、安定した成長を見せており、2020年から2025年の間に約6%のCAGRで成長すると予測されています。 HGHは下垂体によって作り出される子供および大人の成長を刺激するペプチドホルモンです。ホルモンは主に細胞の成長、再生、修復、生殖、代謝を調節し、体全体の発達に貢献します。また、体液、脂肪代謝、骨や筋肉の成長を調節します。 HGHの欠乏は病気や脂肪の蓄積のリスクを高める可能性がありますが、過剰レベルは子供に巨人症、先端巨大症、成人期に筋萎縮性疾患や短腸症候群を引き起こす可能性があります。

ターナー症候群およびその他の成長関連障害の有病率の増加は、市場成長を牽引する重要な要因の1つとなっています。ターナー症候群は、主に女性に影響を与える染色体障害であり、X染色体の完全または部分的な喪失を特徴とします。成長ホルモンはこの病気の症状をいくらか逆転させるためにしばしば投与され、それによって世界中のHGH薬の需要が増えます。さらに、人々の健康意識の高まりと内分泌障害の予防策に関する意識の高まりが、市場成長を後押ししています。プラダー・ウィリー症候群(PWS)や特発性低身長(ISS)などのさまざまな障害は、体内の成長ホルモンの欠乏によって引き起こされますが、医学的に合成されたHGHを使用して治療できます。ボディビルダーによるパフォーマンスエンハンサーとしてのHGHの利用率の上昇や、組換えヒト成長ホルモン(rHGH)の開発など、その他の要因が市場をさらに押し上げると予測されています。

当レポートは世界のヒト成長ホルモン(HGH)市場について調査しており、業界動向、市場予測、アプリケーション・流通チャネル・投与経路別・最終用途産業・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 範囲と調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のヒト成長ホルモン市場

  • 市場概要
  • 市場パフォーマンス

第6章 アプリケーション別市場

  • 成長ホルモン(GH)欠乏症
    • 主な種類
  • ターナー症候群
  • 特発性低身長(ISS)
  • プラダー・ウィリー症候群(PWS)
  • 妊娠期間に比べて小さい胎児
  • その他

第7章 流通チャネル別市場

  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第8章 投与経路別市場

  • 静脈内
  • 筋肉内
  • 皮下
  • 経口

第9章 地域別市場

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別の市場別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロフィール
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring B.V.
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
図表

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2019
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2019
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2019
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: China: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: India: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: France: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 77: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 78: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2020-2025
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2020-2025
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players
目次
Product Code: SR1019J25_Report

The global human growth hormone market (HGH) is currently witnessing strong growth. HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 6% during 2020-2025.

Breakup by Application:

  • Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature (ISS)
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by Route of Administration:

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report:

  • How has the global human growth hormone market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human growth hormone market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Market Types
      • 6.1.2.2 Market Types
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.1 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.1 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.1 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.1 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.1 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio